Hot Jobs

Looking for Career in Pharmacovigilance/ Clinical Research. Enter details here.

Monday, 17 March 2014

Pharmacovigilance Scientist Experience: 0 to 2 yrs. Posted on: 07 Mar

Pharmacovigilance Scientist

by Quantum Solutions India in Chandigarh
Experience: 0 to 2 yrs. Posted on: 07 Mar

Job Description

Send me Jobs like this
Manage activities relating to the processing, follow-up, analysis, and regulatory reporting of adverse events (AEs) and serious adverse events (SAEs) for marketed and investigational products in accordance with the applicable regulatory requirements.
Salary: Best in the industry
Role Category: R&D
Role: Clinical Research Associate/Scientist

Desired Candidate Profile

Education:
UG - B.Sc - Any Specialization, BDS - Dentistry
PG - M.Sc - Any Specialization
Doctorate - Any Doctorate - Any Specialization, Doctorate Not Required
Candidates must have:

1. A Masters degree in Life Sciences (Pharmacy, Microbiology, Biochemistry, Biotechnology or Biophysics) or a degree in Medicine or Dentistry IS A MUST.
Candidates pursuing any of these respective degrees should not apply.
2. Good knowledge of medical terminology.
3. Fluency in written and spoken English
4. Computer proficiency
5. An ability to work with web-based applications, and familiarity with the MS XP, Window 7professional operating system and the MS Office suite (Word / Excel / Power Point), capability to make concise, accurate and relevant synopses of medical text and data, and the ability to write unambiguous medical text, ability to evaluate data and draw conclusions independently,
6. Strong written and oral communications skills


In addition, candidates must be looking for a long term relationship with the organization.

Company Profile

Quantum Solutions India
A Chandigarh-based firm servicing the Pharmaceutical/ Healthcare /Medical industries. The firm specialises in pharmacovigilance work for overseas clients.
Contact Details
Recruiter Name:http://www.qsi.in
Contact Company:Quantum Solutions
Reference Id:PVS


No comments:

Post a Comment

Subscribe to us